FlexTrade Releases Latest Q&A on Best Execution Platform
FlexTrade (@FlexTrade) today released their latest Q&A titled: ‘How will MiFID II impact FX execution for the buy-side?’.
The FlexTRADER EMS currently covers Spot FX and NDFs and other FX derivatives. Except for Spot FX, these are derivatives which are in-scope “financial instruments” in MiFID II.
In this latest Q&A, FlexTrade have partnered with the legal firm Simmons & Simmons to respond to commonly asked questions from buy-side users around FlexTrade’s MTF/OTF status.
You can request your copy of ‘How will MiFID II impact FX execution for the buy-side?’ from FlexTrade’s Best Execution Platform, which showcases FlexTrade’s comprehensive approach to trading during MiFID II.
FlexTrade will be at TradeTechFX next week from September 12-13. Visit us at Booth 2 to learn more about this topic and more.